These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 8080212)

  • 1. Mechanisms and strategies of viral antigenic variation.
    Folks TM
    Ann N Y Acad Sci; 1994 Aug; 730():37-41. PubMed ID: 8080212
    [No Abstract]   [Full Text] [Related]  

  • 2. Genotypic and phenotypic variation of HIV-1: impact on AIDS pathogenesis and vaccination.
    Wolfs TF; Nara PL; Goudsmit J
    Chem Immunol; 1993; 56():1-33. PubMed ID: 8383980
    [No Abstract]   [Full Text] [Related]  

  • 3. Antigenic variation of SIV: mutations in V4 alter the neutralization profile.
    Kinsey NE; Anderson MG; Unangst TJ; Joag SV; Narayan O; Zink MC; Clements JE
    Virology; 1996 Jul; 221(1):14-21. PubMed ID: 8661410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variants selected by treatment of human immunodeficiency virus-infected cells with an immunotoxin.
    Pincus SH; Wehrly K; Tschachler E; Hayes SF; Buller RS; Reitz M
    J Exp Med; 1990 Sep; 172(3):745-57. PubMed ID: 1696955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological consequences of human immunodeficiency virus type 1 envelope polymorphism: does variation matter? 1995 Fleming Lecture.
    McKeating JA
    J Gen Virol; 1996 Dec; 77 ( Pt 12)():2905-19. PubMed ID: 9000081
    [No Abstract]   [Full Text] [Related]  

  • 6. Antigenic structure, evolution and immunobiology of human respiratory syncytial virus attachment (G) protein.
    Melero JA; García-Barreno B; Martínez I; Pringle CR; Cane PA
    J Gen Virol; 1997 Oct; 78 ( Pt 10)():2411-8. PubMed ID: 9349459
    [No Abstract]   [Full Text] [Related]  

  • 7. A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure.
    Binley JM; Sanders RW; Clas B; Schuelke N; Master A; Guo Y; Kajumo F; Anselma DJ; Maddon PJ; Olson WC; Moore JP
    J Virol; 2000 Jan; 74(2):627-43. PubMed ID: 10623724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigenic variation in gp120s from molecular clones of HIV-1 LAI.
    Moore JP; Yoshiyama H; Ho DD; Robinson JE; Sodroski J
    AIDS Res Hum Retroviruses; 1993 Dec; 9(12):1185-93. PubMed ID: 7511394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Structural and functional relationships demonstrated by the study of V3 loop heterogeneity].
    Ruţă S
    Rev Roum Virol; 1993; 44(3-4):289-304. PubMed ID: 7530033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Buffering deleterious polymorphisms in highly constrained parts of HIV-1 envelope by flexible regions.
    Gasser R; Hamoudi M; Pellicciotta M; Zhou Z; Visdeloup C; Colin P; Braibant M; Lagane B; Negroni M
    Retrovirology; 2016 Jul; 13(1):50. PubMed ID: 27473399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of linear antigenic epitopes on GP120 encoded in sibling clones of novel New York HIV-1 subtype B isolates.
    Riley JP; Pestano GA; Harewood K; Alfred LJ; Guyden J; Boto WM
    Cell Mol Biol (Noisy-le-grand); 1995; 41 Suppl 1():S83-91. PubMed ID: 8574151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigenic variation in HIV.
    Putney SD; McKeating JA
    AIDS; 1990; 4 Suppl 1():S129-36. PubMed ID: 2152557
    [No Abstract]   [Full Text] [Related]  

  • 13. Head-to-head comparison on the immunogenicity of two HIV/AIDS vaccine candidates based on the attenuated poxvirus strains MVA and NYVAC co-expressing in a single locus the HIV-1BX08 gp120 and HIV-1(IIIB) Gag-Pol-Nef proteins of clade B.
    Gómez CE; Nájera JL; Jiménez EP; Jiménez V; Wagner R; Graf M; Frachette MJ; Liljeström P; Pantaleo G; Esteban M
    Vaccine; 2007 Apr; 25(15):2863-85. PubMed ID: 17113200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presence of maternal antibodies to human immunodeficiency virus 1 envelope glycoprotein gp120 epitopes correlates with the uninfected status of children born to seropositive mothers.
    Rossi P; Moschese V; Broliden PA; Fundaró C; Quinti I; Plebani A; Giaquinto C; Tovo PA; Ljunggren K; Rosen J
    Proc Natl Acad Sci U S A; 1989 Oct; 86(20):8055-8. PubMed ID: 2479014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroreactivity of analogous antigenic epitopes in glycoprotein 120 expressed in HIV-1 subtypes A, B, C, and D.
    Pestano GA; Hosford KS; Spira AI; Riley J; Xie JM; Sewankambo N; Brown L; Ho DD; Boto WM
    AIDS Res Hum Retroviruses; 1995 May; 11(5):589-96. PubMed ID: 7576915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and characterization of an orf virus homologue of the vaccinia virus gene encoding the major envelope antigen p37K.
    Sullivan JT; Mercer AA; Fleming SB; Robinson AJ
    Virology; 1994 Aug; 202(2):968-73. PubMed ID: 8030257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conservation of human immunodeficiency virus type 1 gp120 inner-domain sequences in lentivirus and type A and B retrovirus envelope surface glycoproteins.
    Hötzel I; Cheevers WP
    J Virol; 2001 Feb; 75(4):2014-8. PubMed ID: 11160703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of HIV-1 antigenic diversification using serum as sample source.
    Goudsmit J; Zwart G; Wolfs T
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1473. PubMed ID: 1466985
    [No Abstract]   [Full Text] [Related]  

  • 19. Transgenic mice as models of human immunodeficiency virus expression and related cellular effects.
    Brady HJ; Pennington DJ; Dzierzak EA
    J Gen Virol; 1994 Oct; 75 ( Pt 10)():2549-58. PubMed ID: 7931142
    [No Abstract]   [Full Text] [Related]  

  • 20. Vaccines against HIV.
    Carmichael AJ; Sissons JG
    QJM; 1995 Feb; 88(2):77-9. PubMed ID: 7704566
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.